SZSE:301060 (China)
Â
Class A
Â¥
8.87
-0.050 (-0.56%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Shanghai Labway Clinical Laboratory Co Ltd
ISIN : CNE100004RG8
Share Class Description:
SZSE:301060: Class ACompare
Compare
Traded in other countries / regions
301060.China IPO Date
2021-09-13Description
Shanghai Labway Clinical Laboratory Co Ltd provides comprehensive health management solutions relying on medical laboratory and pathological diagnosis services. It offers genetic testing, clinical microbiology testing, blood and pathology testing, cytopathological diagnosis, and other services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.18 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -1.51 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.18 | |||||
| Beneish M-Score | -1.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6 | |||||
| 3-Year FCF Growth Rate | 1.9 | |||||
| 3-Year Book Growth Rate | 8.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.92 | |||||
| 9-Day RSI | 42.71 | |||||
| 14-Day RSI | 41.51 | |||||
| 3-1 Month Momentum % | 10.76 | |||||
| 6-1 Month Momentum % | -11.23 | |||||
| 12-1 Month Momentum % | 0.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.45 | |||||
| Quick Ratio | 2.93 | |||||
| Cash Ratio | 1.17 | |||||
| Days Inventory | 88.31 | |||||
| Days Sales Outstanding | 226.37 | |||||
| Days Payable | 111.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.4 | |||||
| Shareholder Yield % | -2.36 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.23 | |||||
| Operating Margin % | -1.58 | |||||
| Net Margin % | -10.51 | |||||
| FCF Margin % | 9.53 | |||||
| ROE % | -10.07 | |||||
| ROA % | -6.27 | |||||
| ROIC % | -1.56 | |||||
| 3-Year ROIIC % | -18.04 | |||||
| ROC (Joel Greenblatt) % | -14.4 | |||||
| ROCE % | -9.59 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 18.48 | |||||
| PS Ratio | 2.06 | |||||
| PB Ratio | 2.05 | |||||
| Price-to-Tangible-Book | 2.09 | |||||
| Price-to-Free-Cash-Flow | 21.74 | |||||
| Price-to-Operating-Cash-Flow | 13.52 | |||||
| EV-to-EBIT | -16.24 | |||||
| EV-to-EBITDA | -16.24 | |||||
| EV-to-Revenue | 1.96 | |||||
| EV-to-FCF | 20.12 | |||||
| Price-to-GF-Value | 0.83 | |||||
| Price-to-Projected-FCF | 2.03 | |||||
| Price-to-Net-Current-Asset-Value | 3.29 | |||||
| Earnings Yield (Greenblatt) % | -6.16 | |||||
| FCF Yield % | 4.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Labway Clinical Laboratory Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,724.522 | ||
| EPS (TTM) (Â¥) | -0.454 | ||
| Beta | 1.42 | ||
| 3-Year Sharpe Ratio | -0.97 | ||
| 3-Year Sortino Ratio | -1.11 | ||
| Volatility % | 45.41 | ||
| 14-Day RSI | 41.51 | ||
| 14-Day ATR (Â¥) | 0.407157 | ||
| 20-Day SMA (Â¥) | 9.0615 | ||
| 12-1 Month Momentum % | 0.92 | ||
| 52-Week Range (Â¥) | 7.46 - 13.26 | ||
| Shares Outstanding (Mil) | 400.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Labway Clinical Laboratory Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Labway Clinical Laboratory Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Labway Clinical Laboratory Co Ltd Frequently Asked Questions
What is Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060)'s stock price today?
The current price of SZSE:301060 is ¥8.87. The 52 week high of SZSE:301060 is ¥13.26 and 52 week low is ¥7.46.
When is next earnings date of Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060)?
The next earnings date of Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060) is .
Does Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060) pay dividends? If so, how much?
Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers